Methods and compositions for diagnosis and monitoring of atherosclerotic cardiovascular disease

Details for Australian Patent Application No. 2006261779 (hide)

Owner The Board of Trustees of the Leland Stanford Junior University

Inventors Hytopoulos, Evangelos; Tsao, Philip S.; Tabibiazar, Raymond; Olshen, Richard A.; Quertermous, Thomas; Turnbull, Brit Katzen

Agent FB Rice

Pub. Number AU-A-2006261779

PCT Pub. Number WO2007/002677

Priority 11/473,826 23.06.06 US; 60/693,756 24.06.05 US

Filing date 26 June 2006

Wipo publication date 4 January 2007

International Classifications

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G06F 19/00 (2006.01) Digital computing or data processing equipment or methods, specially adapted for specific applications

Event Publications

24 January 2008 PCT application entered the National Phase

  PCT publication WO2007/002677 Priority application(s): WO2007/002677

3 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006261780-Method and apparatus for reservoir fluid characterization in nuclear magnetic resonance logging

2006261764-Anti-inflammatory, radioprotective, and longevity enhancing capabilities of cerium oxide nanoparticles